hMLH1 promoter methylation and BRAF mutations in high-Frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines

Annals of Surgical Treatment and Research

Volumn 87, Issue 3, 2014, Pages 123-130

  Kim, Sang Jin ^a   Kim, Hyoung Ran ^a   Kim, Seok Hyung ^a   Han, Ji Hye ^a   Cho, Yong Beom ^a   Yun, Seong Hyeon ^a   Lee, Woo Yong ^a   Kim, Hee Cheol ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

BRAF; Colorectal neoplasms; Hereditary colorectal cancer; HMLH1

Indexed keywords

EID: 84986882880     PISSN: 22886575     EISSN: 22886796     Source Type: Journal    
DOI: 10.4174/astr.2014.87.3.123     Document Type: Article

References (26)

1. Jacob S, Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 2002;84:27-47.
2. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colo rectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-7.
3. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Can cer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110:1020-7.
4. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87:159-70.
5. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorec tal cancer: database and results of a collaborative study. The International Colla borative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroente rology 1997;113:1146-58.
6. Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004;22:4934-43.
7. Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, et al. Incor poration of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorec tal cancer. Fam Cancer 2007;6:301-10.
8. Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641-5.
9. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-60.
10. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004;10(1 Pt 1): 191-5.
11. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
12. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
13. Odenthal M, Barta N, Lohfink D, Drebber U, Schulze F, Dienes HP, et al. Analysis of microsatellite instability in colorectal carcinoma by microfluidic-based chip electrophoresis. J Clin Pathol 2009;62:850-2.
14. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339:511-8.
15. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8.
16. Urso E, Pucciarelli S, Agostini M, Maretto I, Mescoli C, Bertorelle R, et al. Proximal colon cancer in patients aged 51-60 years of age should be tested for microsatellites instability. A comment on the Revised Bethesda Guidelines. Int J Colorectal Dis 2008;23:801-6.
17. Berginc G, Bracko M, Ravnik-Glavac M, Glavac D. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Fam Cancer 2009;8:421-9.
18. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interre lationship between genetics and epigenetics. Carcinogenesis 2008;29:673-80.
19. Lawes DA, Pearson T, Sengupta S, Boulos PB. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer 2005;93:472-7.
20. Hatch SB, Lightfoot HM Jr, Garwacki CP, Moore DT, Calvo BF, Woosley JT, et al. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors. Clin Cancer Res 2005;11:2180-7.
21. Rigau V, Sebbagh N, Olschwang S, Paraf F, Mourra N, Parc Y, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining. Arch Pathol Lab Med 2003;127: 694-700.
22. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, et al. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern coun tries. Clin Cancer Res 2005;11:8281-7.
23. Mead LJ, Jenkins MA, Young J, Royce SG, Smith L, St John DJ, et al. Microsatellite instability markers for identifying earlyonset colorectal cancers caused by germline mutations in DNA mismatch repair genes. Clin Cancer Res 2007;13:2865-9.
24. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002;418: 934.
25. Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004;41:664-8.
26. McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, et al. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 2004;3:101-7.